Ana Rubio
Papers
1
Total Citations
7
H-Index
1
About
Dr. Ana Rubio is a leading figure in serological diagnostics, with a focused expertise in developing minimally invasive methods for detecting infectious diseases. Her most cited work, "Detection of anti‐SARS‐CoV‐2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA)" (2021, 7 citations), addresses a critical need during the COVID-19 pandemic by validating the use of dried blood spot (DBS) specimens for antibody testing. This contribution enables reliable, at-home or remote sampling, reducing the burden on healthcare systems while maintaining diagnostic accuracy through both manual and automated extraction techniques paired with ECLIA. Dr. Rubio’s research bridges practical public health challenges with advanced immunoassay technology, offering scalable solutions for pandemic management. Her work has been instrumental in expanding access to serological surveillance, particularly in resource-limited settings. With a growing citation impact, Dr. Rubio continues to influence the field of infectious disease diagnostics, emphasizing innovation in sample collection and laboratory automation to improve global health outcomes.
Research Focus
Key Achievements
Top Papers
- 1